174 related articles for article (PubMed ID: 26107665)
21. Prognostic impact of tumor IL-6 expression after preoperative chemoradiotherapy in patients with advanced esophageal squamous cell carcinoma.
Yoneda M; Fujiwara H; Furutani A; Ikai A; Tada H; Shiozaki A; Komatsu S; Kubota T; Ichikawa D; Okamoto K; Konishi H; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Ochiai T; Otsuji E
Anticancer Res; 2013 Jun; 33(6):2699-705. PubMed ID: 23749929
[TBL] [Abstract][Full Text] [Related]
22. Serum soluble E-cadherin is a potential prognostic marker in esophageal squamous cell carcinoma.
Chung Y; Law S; Kwong DL; Luk JM
Dis Esophagus; 2011 Jan; 24(1):49-55. PubMed ID: 20807231
[TBL] [Abstract][Full Text] [Related]
23. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma.
Barbetta A; Hsu M; Tan KS; Stefanova D; Herman K; Adusumilli PS; Bains MS; Bott MJ; Isbell JM; Janjigian YY; Ku GY; Park BJ; Wu AJ; Jones DR; Molena D
J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2710-2721.e3. PubMed ID: 29548582
[TBL] [Abstract][Full Text] [Related]
24. The prognostic value of circumferential resection margin in esophageal squamous cell carcinoma after concurrent chemoradiation therapy and surgery.
Liu CY; Wang BY; Lee MY; Tsai YC; Liu CC; Shih CH
J Chin Med Assoc; 2013 Oct; 76(10):570-5. PubMed ID: 23938149
[TBL] [Abstract][Full Text] [Related]
25. Survival after neoadjuvant chemoradiotherapy and oesophagectomy versus definitive chemoradiotherapy for patients with oesophageal squamous cell carcinoma.
Wang BY; Wu SC; Chen HC; Hung WH; Lin CH; Huang CL; Chen HS
Br J Surg; 2019 Feb; 106(3):255-262. PubMed ID: 30395362
[TBL] [Abstract][Full Text] [Related]
26. Postchemoradiotherapy Pathologic Stage Classified by the American Joint Committee on the Cancer Staging System Predicts Prognosis of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma.
Guo JC; Huang TC; Lin CC; Hsieh MS; Chang CH; Huang PM; Lee JM; Hsu FM; Chia-Hsien Cheng J; Wang HP; Yeh KH; Cheng AL; Hsu CH
J Thorac Oncol; 2015 Oct; 10(10):1481-9. PubMed ID: 26313683
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
Guttmann DM; Mitra N; Metz JM; Plastaras J; Feng W; Swisher-McClure S
J Geriatr Oncol; 2018 Jan; 9(1):40-46. PubMed ID: 28887066
[TBL] [Abstract][Full Text] [Related]
28. Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Overall Survival in Esophageal Cancer Patients.
Azab B; Amundson JR; Picado O; Ripat C; Macedo FI; Franceschi D; Livingstone AS; Yakoub D
Ann Surg Oncol; 2019 Mar; 26(3):861-868. PubMed ID: 30311162
[TBL] [Abstract][Full Text] [Related]
29. Utility of weekly docetaxel combined with preoperative radiotherapy for locally advanced esophageal cancer from pathological analysis.
Kushida T; Nohara S; Yoshino K; Fujiwara D; Ouchi K; Amano T; Isayama F; Tomita N; Iwanuma Y; Sasai K; Tsurumaru M; Kajiyama Y
Dis Esophagus; 2014; 27(4):368-73. PubMed ID: 23865505
[TBL] [Abstract][Full Text] [Related]
30. Postoperative chemoradiotherapy improves survival in patients with stage II-III esophageal squamous cell carcinoma: An analysis of clinical outcomes.
Zou B; Pang J; Liu Y; Xu Y; Li L; Zhou L; Zhu J; Huang M; Wang J; Ren L; Gong Y; Lu Y; Chen L; Peng F
Thorac Cancer; 2016 Sep; 7(5):515-521. PubMed ID: 27766781
[TBL] [Abstract][Full Text] [Related]
31. Tumor Remission and Tumor-Infiltrating Lymphocytes During Chemoradiation Therapy: Predictive and Prognostic Markers in Locally Advanced Esophageal Squamous Cell Carcinoma.
Qian D; Wang Y; Zhao G; Cao F; Er P; Chen X; Cheng J; Zhang W; Li X; Zhang B; Guan Y; Zhou D; Wang J; Jiang H; Yu Z; Yuan Z; Wang P; Pang Q
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):319-328. PubMed ID: 31228553
[TBL] [Abstract][Full Text] [Related]
32. A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy.
Yu S; Zhang W; Ni W; Xiao Z; Wang Q; Zhou Z; Feng Q; Zhang H; Chen D; Liang J; Lv J; Hui Z; He J; Gao S; Sun K; Fang D; Liu X; Li Y
Radiother Oncol; 2019 Nov; 140():159-166. PubMed ID: 31302346
[TBL] [Abstract][Full Text] [Related]
33. Post-chemoradiotherapy FDG PET with qualitative interpretation criteria for outcome stratification in esophageal squamous cell carcinoma.
Huang YC; Li SH; Lu HI; Hsu CC; Wang YM; Lin WC; Chen CJ; Ho KW; Chiu NT
PLoS One; 2019; 14(1):e0210055. PubMed ID: 30615636
[TBL] [Abstract][Full Text] [Related]
34. Cervical Esophageal Cancer Treatment Strategies: A Cohort Study Appraising the Debated Role of Surgery.
Valmasoni M; Pierobon ES; Zanchettin G; Briscolini D; Moletta L; Ruol A; Salvador R; Merigliano S
Ann Surg Oncol; 2018 Sep; 25(9):2747-2755. PubMed ID: 29987601
[TBL] [Abstract][Full Text] [Related]
35. Postoperative chemoradiotherapy improves survival in esophageal squamous cell cancer with extracapsular lymph node extension.
Wang ZW; Luan ZP; Zhang W; Dong W; Fu CR; Wang YN; Li BS
Neoplasma; 2014; 61(6):732-8. PubMed ID: 25150318
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion.
Yoshimizu S; Yoshio T; Ishiyama A; Tsuchida T; Horiuchi Y; Omae M; Hirasawa T; Asari T; Chin K; Fujisaki J
Dig Liver Dis; 2018 Aug; 50(8):833-838. PubMed ID: 29477349
[TBL] [Abstract][Full Text] [Related]
37. Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes.
Shao MS; Wong AT; Schwartz D; Weiner JP; Schreiber D
Ann Thorac Surg; 2016 Jun; 101(6):2148-54. PubMed ID: 27016842
[TBL] [Abstract][Full Text] [Related]
38. The usefulness of neoadjuvant chemoradiation therapy for locally advanced esophageal cancer with multiple lymph-node metastases.
Okumura H; Uchikado Y; Omoto I; Kita Y; Sasaki K; Arigami T; Uenosono Y; Matsushita D; Hiraki Y; Owaki T; Ishigami S; Natsugoe S
Ann Surg Oncol; 2014 Sep; 21(9):2845-9. PubMed ID: 24728820
[TBL] [Abstract][Full Text] [Related]
39. Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort.
Smith GL; Smith BD; Buchholz TA; Liao Z; Jeter M; Swisher SG; Hofstetter WL; Ajani JA; McAleer MF; Komaki R; Cox JD
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):482-9. PubMed ID: 19289262
[TBL] [Abstract][Full Text] [Related]
40. Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy.
Law S; Kwong DL; Kwok KF; Wong KH; Chu KM; Sham JS; Wong J
Ann Surg; 2003 Sep; 238(3):339-47; discussion 347-8. PubMed ID: 14501500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]